Feed aggregator

NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against VNET Group, Inc. (“VNET” or the “Company”) (NASDAQ: VNET) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired VNET securities between April 8, 2022 and February 15, 2023, both dates inclusive (the “Class Period”). Investors have

NEW YORK--(BUSINESS WIRE)---- $EH #EH--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of EHang Holdings Limited (NASDAQ: EH) between January 20, 2022 and November 6, 2023, both dates inclusive (the “Class Period”), of the important February 2, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased EHang securities during the Class Period you may be entitled to compensation without payment of any out of poc

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of RayzeBio, Inc. (NasdaqGM: RYZB) to Bristol-Myers Squibb Company (NYSE: BMY). Under the terms of the proposed transaction, shareholders of RayzeBio will receive $62.50 in cash for each share of RayzeBio that they own. KSF is seeking to determine whether this consideration and the process that led to it are adeq

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Theseus Pharmaceuticals, Inc. (NasdaqGS: THRX) to Concentra Biosciences, LLC. Under the terms of the proposed transaction, shareholders of Theseus will receive between $3.90 and $4.05 in cash for each share of Theseus that they own. KSF is seeking to determine whether this consideration and the process that le

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Gracell Biotechnologies Inc. (NasdaqGS: GRCL) to AstraZeneca. Under the terms of the proposed transaction, shareholders of Gracell will receive $2.00 per ordinary share in cash at closing (equivalent to $10.00 per ADS of Gracell), plus a non-tradable contingent value right of $0.30 per ordinary share in cash (

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Daseke, Inc. (NasdaqCM: DSKE) to TFI International Inc. Under the terms of the proposed transaction, shareholders of Daseke will receive $8.30 in cash for each common share of Daseke that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether th

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Karuna Therapeutics, Inc. (NasdaqGM: KRTX) to Bristol-Myers Squibb Company (NYSE: BMY). Under the terms of the proposed transaction, shareholders of Karuna will receive $330.00 in cash for each share of Karuna that they own. KSF is seeking to determine whether this consideration and the process that led to it

BOSTON--(BUSINESS WIRE)--Boston Millennia Partners (“Boston Millennia”), a significant shareholder of SomaLogic (the “Company”) (Nasdaq: SLGC) today announced that it intends to vote against the Company’s planned merger (the “Merger”) with Standard BioTools Inc. (Nasdaq: LAB).

NEW YORK--(BUSINESS WIRE)---- $DG #DG--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dollar General Corporation (NYSE: DG) between May 28, 2020 and August 30, 2023, both dates inclusive (the “Class Period”), of the January 26, 2024 lead plaintiff deadline. SO WHAT: If you purchased Dollar General common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WH

NEW YORK--(BUSINESS WIRE)---- $CHPT #CHPT--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ChargePoint Holdings, Inc. (NYSE: CHPT) between June 1, 2023 and November 16, 2023, both dates inclusive (the “Class Period”), of the important January 29, 2024 lead plaintiff deadline. SO WHAT: If you purchased ChargePoint securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangem

NEW YORK--(BUSINESS WIRE)---- $BCLI #BCLI--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between August 15, 2022 and September 27, 2023, both dates inclusive (the “Class Period”), of the important January 2, 2024 lead plaintiff deadline in the securities class action commenced by the Firm. SO WHAT: If you purchased Brainstorm Cell securities during the Class Period you may be entitled to compensation without paym

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Barclays PLC (NYSE: BCS) (OTC: BCLYF) between July 22, 2019 and October 12, 2023, both dates inclusive (the “Class Period”), of the important January 2, 2024 lead plaintiff deadline in the securities class action commenced by the Firm. SO WHAT: If you purchased Barclays securities during the Class Period you may be entitled to compensation without payment of any out of pock